Articles producció científica> Medicina i Cirurgia

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges

  • Dades identificatives

    Identificador: imarina:5132577
    Autors:
    Gourlay A., Noori T., Pharris A., Axelsson M., Costagliola D., Cowan S., Croxford S., D'arminio Monforte A., Del Amo J., Delpech V., Díaz A., Girardi E., Gunsenheimer-Bartmeyer B., Hernando V., Jose S., Leierer G., Nikolopoulos G., Obel N., Op De Coul E., Paraskeva D., Reiss P., Sabin C., Sasse A., Schmid D., Sonnerborg A., Spina A., Suligoi B., Supervie V., Touloumi G., Van Beckhoven D., Van Sighem A., Vourli G., Zangerle R., Porter K.
    Resum:
    BACKGROUND.: The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a '90-90-90' target to curb the human immunodeficiency virus (HIV) epidemic by 2020, but methods used to assess whether countries have reached this target are not standardized, hindering comparisons. METHODS.: Through a collaboration formed by the European Centre for Disease Prevention and Control (ECDC) with European HIV cohorts and surveillance agencies, we constructed a standardized, 4-stage continuum of HIV care for 11 European Union countries for 2013. Stages were defined as (1) number of people living with HIV in the country by end of 2013; (2) proportion of stage 1 ever diagnosed; (3) proportion of stage 2 that ever initiated ART; and (4) proportion of stage 3 who became virally suppressed (≤200 copies/mL). Case surveillance data were used primarily to derive stages 1 (using back-calculation models) and 2, and cohort data for stages 3 and 4. RESULTS.: In 2013, 674500 people in the 11 countries were estimated to be living with HIV, ranging from 5500 to 153400 in each country. Overall HIV prevalence was 0.22% (range, 0.09%-0.36%). Overall proportions of each previous stage were 84% diagnosed, 84% on ART, and 85% virally suppressed (60% of people living with HIV). Two countries achieved ≥90% for all stages, and more than half had reached ≥90% for at least 1 stage. CONCLUSIONS.: European Union countries are nearing the 90-90-90 target. Reducing the proportion undiagnosed remains the greatest barrier to achieving this target, suggesting that further efforts are needed to improve HIV testing rates. Standardizing methods to derive comparable continuums of care remains a challenge.
  • Altres:

    Autor segons l'article: Gourlay A., Noori T., Pharris A., Axelsson M., Costagliola D., Cowan S., Croxford S., D'arminio Monforte A., Del Amo J., Delpech V., Díaz A., Girardi E., Gunsenheimer-Bartmeyer B., Hernando V., Jose S., Leierer G., Nikolopoulos G., Obel N., Op De Coul E., Paraskeva D., Reiss P., Sabin C., Sasse A., Schmid D., Sonnerborg A., Spina A., Suligoi B., Supervie V., Touloumi G., Van Beckhoven D., Van Sighem A., Vourli G., Zangerle R., Porter K.
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Vidal Marsal, Francisco
    Paraules clau: Surveillance Hiv infection Continuum of care Cohort analysis Antiretroviral therapy. hiv infection continuum of care cohort analysis antiretroviral therapy.
    Resum: BACKGROUND.: The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a '90-90-90' target to curb the human immunodeficiency virus (HIV) epidemic by 2020, but methods used to assess whether countries have reached this target are not standardized, hindering comparisons. METHODS.: Through a collaboration formed by the European Centre for Disease Prevention and Control (ECDC) with European HIV cohorts and surveillance agencies, we constructed a standardized, 4-stage continuum of HIV care for 11 European Union countries for 2013. Stages were defined as (1) number of people living with HIV in the country by end of 2013; (2) proportion of stage 1 ever diagnosed; (3) proportion of stage 2 that ever initiated ART; and (4) proportion of stage 3 who became virally suppressed (≤200 copies/mL). Case surveillance data were used primarily to derive stages 1 (using back-calculation models) and 2, and cohort data for stages 3 and 4. RESULTS.: In 2013, 674500 people in the 11 countries were estimated to be living with HIV, ranging from 5500 to 153400 in each country. Overall HIV prevalence was 0.22% (range, 0.09%-0.36%). Overall proportions of each previous stage were 84% diagnosed, 84% on ART, and 85% virally suppressed (60% of people living with HIV). Two countries achieved ≥90% for all stages, and more than half had reached ≥90% for at least 1 stage. CONCLUSIONS.: European Union countries are nearing the 90-90-90 target. Reducing the proportion undiagnosed remains the greatest barrier to achieving this target, suggesting that further efforts are needed to improve HIV testing rates. Standardizing methods to derive comparable continuums of care remains a challenge.
    Àrees temàtiques: Saúde coletiva Odontología Microbiology (medical) Microbiology Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Infectious diseases Immunology General medicine Farmacia Engenharias ii Engenharias i Enfermagem Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Biodiversidade
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 10584838
    Adreça de correu electrònic de l'autor: francesc.vidal@urv.cat
    Identificador de l'autor: 0000-0002-6692-6186
    Data d'alta del registre: 2024-09-07
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://academic.oup.com/cid/article/64/12/1644/3075165
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Clinical Infectious Diseases. 64 (12): 1644-1656
    Referència de l'ítem segons les normes APA: Gourlay A., Noori T., Pharris A., Axelsson M., Costagliola D., Cowan S., Croxford S., D'arminio Monforte A., Del Amo J., Delpech V., Díaz A., Girardi (2017). The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges. Clinical Infectious Diseases, 64(12), 1644-1656. DOI: 10.1093/cid/cix212
    DOI de l'article: 10.1093/cid/cix212
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2017
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Immunology,Infectious Diseases,Microbiology,Microbiology (Medical)
    Surveillance
    Hiv infection
    Continuum of care
    Cohort analysis
    Antiretroviral therapy.
    hiv infection
    continuum of care
    cohort analysis
    antiretroviral therapy.
    Saúde coletiva
    Odontología
    Microbiology (medical)
    Microbiology
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    Infectious diseases
    Immunology
    General medicine
    Farmacia
    Engenharias ii
    Engenharias i
    Enfermagem
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Biotecnología
    Biodiversidade
  • Documents:

  • Cerca a google

    Search to google scholar